Skip to main content
. 2019 Nov 20;57(4):469–478. doi: 10.1007/s00592-019-01439-x

Fig. 3.

Fig. 3

Mean change in BCVA in pseudophakic eyes switched either directly (Group A; Panel A) or indirectly (Group B; Panel B) from anti-VEGF therapy to FAc implant. BCVA best-corrected visual acuity, ETDRS early treatment diabetic retinopathy study, FAc fluocinolone acetonide, VEGF vascular endothelial growth factor